logo logo

Back to blood pressure news index

Viagra Ingredient Approved by FDA for Pulmonary Hypertension

Source: WebMD
Viagra’s key ingredient has been approved by the FDA to treat
pulmonary hypertension.

Source: Pfizer
Revatio offers new treatment for pulmonary hypertension.

Other sources: Yahoo , FoxNews

Our Summary

The big news of the week was the FDA approval of the key ingredient
in Viagra to treat Pulmonary Hypertension. Pulmonary Hypertension
is a life-shortening lung disorder that causes continuous high
blood pressure in the lungs. The Pulmonary Hypertension Association
website offers great insight into this rare and complex disorder.

Viagra’s maker, Pfizer will repackage Viagra’s key ingredient
(sildenafil) and market it as Revatio. According to Joseph
Feczko, M.D., president of Worldwide Development Pfizer. “PAH
(pulmonary arterial hypertension) is a condition for which new
treatment options are desperately needed.
” Pfizer also states,
PAH, often referred to as high blood pressure of the lungs,
affects approximately 100,000 people in North America and Europe.
Those afflicted are usually women between the ages of 21 and 50.

This new treatment option will hopefully offer help to sufferers of
pulmonary hypertension.

Back to blood pressure news index

bottom


bottom KellieMyHS

About Kellie

Kellie is 37 years old and together with her brother Steve makes up the My Health Software team.

She helps on the websites and gathering news for the programs. Kellie worked in the medical industry prior to having her two children (8 and 6) and has a strong interest in self awareness and management of health conditions.


bottom